Citations

Showing 10 of 108152 citations.

Improving Distress and Behaviors for Parents of Adolescents With Chronic Pain Enrolled in an Intensive Interdisciplinary Pain Program
Weiss, Karen , Junghans-Rutelonis, Ashley N. , Harbeck‐Weber, Cynthia , McTate, Emily , Luedtke, Connie A. , Bruce, Barbara K. , HARBECK-WEBER, CYNTHIA, Luedtke, Connie, McTate, Emily , Aaron, Rachel V. , Harbeck‐Weber, Cynthia

Mayo Clinic

The Clinical Journal of Pain | June 15, 2019 | Volume: 35 | Issue: 9 | Pages: 772-779

10.1097/ajp.0000000000000737 | PMID 31205071 Get It

Objectives: Intensive interdisciplinary treatment is emerging as an effective treatment of chronic pain in youth. These programs often include a parental component with the belief that targeting parental distress and responses to a child’s pain will improve outcomes. However, few studies have evaluated the impact of a parental intervention in the interdisciplinary treatment of pediatric chronic pain. The present study consists of a nonrandomized pre-post design to evaluate change in psychological and behavioral functioning of parents who participated in intensive parent programming that utilized cognitive-behavioral therapy and acceptance and commitment therapy, delivered within the context of an interdisciplinary intensive 3-week pain treatment program for youth with chronic pain. Materials and Methods: Two hundred twelve parents and their children participated in the study, with 116 participants completing 3-month follow-up measures. Parents completed measures of depressive symptoms, pain catastrophizing, protective responses, and psychological flexibility at admission, discharge, and 3 months after the program. Child functional disability was assessed at the same time points. We examined change in parent factors over time, while controlling for change in child distress. Results: Parents reported significant improvements in all areas of functioning from admission to discharge and improvements were maintained at 3-month follow-up. Discussion: This study provides evidence suggesting parent interventions can be effective in reducing parent distress and behaviors known to be associated with child outcomes.
Development and validation of the Skills Assessment in Microsurgery for Brain Aneurysms (SAMBA) instrument for predicting proficiency in aneurysm surgery
Oliveira, Marcelo Magaldi Ribeiro de , Ramos, Taise Mosso, Ferrarez, Carlos Eduardo , Alvarenga, Daniel L., Soares, Carolina K., Mainart, Luiza M., Aguilar‐Salinas, Pedro , Gusmão, Sebastião , Sauvageau, Eric , Machado, Carla Jorge , Costa, Pollyana Helena Vieira , Soares, Carolina Kuchenbecker , Hanel, Ricardó A. , Lanzino, Giuseppe

Mayo Clinic

Journal of Neurosurgery | June 14, 2019 | Volume: 133 | Issue: 1 | Pages: 190-196

10.3171/2018.7.jns173007 | PMID 31200371 Get It

OBJECTIVESurgical performance evaluation was first described with the OSATS (Objective Structured Assessment of Technical Skills) and modified for aneurysm microsurgery simulation with the OSAACS (Objective Structured Assessment of Aneurysm Clipping Skills). These methods rely on the subjective opinions of evaluators, however, and there is a lack of objective evaluation for proficiency in the microsurgical treatment of brain aneurysms. The authors present a new instrument, the Skill Assessment in Microsurgery for Brain Aneurysms (SAMBA) scale, which can be used similarly in a simulation model and in the treatment of unruptured middle cerebral artery (MCA) aneurysms to predict surgical performance; the authors also report on its validation.METHODSThe SAMBA scale was created by consensus among 5 vascular neurosurgeons from 2 different neurosurgical departments. SAMBA results were analyzed using descriptive statistics, Cronbach’s alpha indexes, and multivariate ANOVA analyses (p < 0.05).RESULTSExpert, intermediate-level, and novice surgeons scored, respectively, an average of 33.9, 27.1, and 16.4 points in the real surgery and 33.3, 27.3, and 19.4 points in the simulation. The SAMBA interrater reliability index was 0.995 for the real surgery and 0.996 for the simulated surgery; the intrarater reliability was 0.983 (Cronbach’s alpha). In both the simulation and the real surgery settings, the average scores achieved by members of each group (expert, intermediate level, and novice) were significantly different (p < 0.001). Scores among novice surgeons were more diverse (coefficient of variation = 12.4).CONCLUSIONSPredictive validation of the placenta brain aneurysm model has been previously reported, but the SAMBA scale adds an objective scoring system to verify microsurgical ability in this complex operation, stratifying proficiency by points. The SAMBA scale can be used as an interface between learning and practicing, as it can be applied in a safe and controlled environment, such as is provided by a placenta model, with similar results obtained in real surgery, predicting real surgical performance.
Long-term Outcomes Following Kidney Transplantation From Donors With Acute Kidney Injury
Heilman, Raymond L. , Kumar, Anjushree , Srinivasan, Ananth, Huskey, Janna L. , Khamash, Hasan , Mathur, Amit K. , Moss, Adyr A. , Reddy, Kunam S. , Khamash, Hasan A, Smith, Maxwell L. , Smith, Byron H. , Srinivasan, Ananth, Jadlowiec, Caroline C.

Mayo Clinic

Transplantation | June 14, 2019 | Volume: 103 | Issue: 9 | Pages: e263-e272

10.1097/tp.0000000000002792 | PMID 31205261 Get It

Background. Kidneys from deceased donors with acute kidney injury (AKI) are more likely to be discarded because of concerns for poor outcomes after transplantation. The aim of this study was to determine the long-term outcomes of a large cohort of patients transplanted utilizing kidneys from deceased donors with AKI. Methods. All patients receiving a deceased donor kidney transplant during a recent 10-year period were included. Acute Kidney Injury Network (AKIN) criteria were used to classify the donors. Donor kidneys with >10% cortical necrosis or more than mild chronic changes were discarded. The primary outcome is the combined endpoint of death or graft loss. Results. The cohort included 1313 kidneys from 974 donors, AKIN stage 0 (no AKI) in 319 (24.3%), stage 1 in 370 (28.2%), stage 2 in 177 (13.5), and stage 3 in 447 (34.0%). Estimated 5-year graft survival (95% confidence interval) was 78.5% (72.5-84.5), 77.8% (72.8-82.1), 83.8% (76.8-88.9), and 84.6% (79.5-88.7) for AKIN donor stage 0 to 3, respectively (log-rank P = 0.10). After adjusting for baseline differences, the hazard ratio (95% confidence interval) for the combined endpoint for the AKIN stage 3 group (relative to AKIN 0 group) was 0.70 (0.45-1.10). Delayed graft function occurred in 44.6% and 75.4% of AKIN 2 and 3 groups, as compared to 33.9% and 33.5% in AKIN 0 and 1 ( P < 0.001). Conclusion. We conclude that transplanting selected kidneys from deceased donors with AKI with preimplantation biopsy showing <10% cortical necrosis and no more than mild chronic changes have excellent long-term graft survival.
Response to Lai
Lacy, Brian E. , Schoenfeld, Philip , Dove, Leonard S., Covington, Paul S., Cash, Brooks D.

Mayo Clinic

American Journal of Gastroenterology | June 14, 2019 | Volume: 114 | Issue: 7 | Pages: 1177-1178

10.14309/ajg.0000000000000312 | PMID 31205133 Get It

Introduction to the Gut Microbiome Special Issue
Lacy, Brian E. , Spiegel, Brennan , Spiegel, Brennan

Mayo Clinic

American Journal of Gastroenterology | June 14, 2019 | Volume: 114 | Issue: 7 | Pages: 1013-1013

10.14309/ajg.0000000000000303 | PMID 31205134 Get It

Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management
Vivian, Elaina , Cler, Leslie, Conwell, Darwin L. , Coté, Gregory A. , Dickerman, Richard, Freeman, Martin L. , Gardner, Timothy B. , Hawes, Robert H. , Kedia, Prashant , Krishnamoorthi, Rajesh , Oduor, Hellen , Ross, Andrew , Sethi, Amrita , Varadarajulu, Shyam , Vege, Santhi Swaroop , Wassef, Wahid , Wilcox, C. Mel, Yadav, Dhiraj , Ellison, Ashton , Habash, Samar, Rastegari, Sheila , Reddy, Rathan , Yen, Timothy , Tarnasky, Paul R., Pandol, Stephen J. , Papachristou, Georgios I. , Whitcomb, David C. , Wu, Bechien U. , Brooks, Mary Rachel

Mayo Clinic

American Journal of Gastroenterology | June 14, 2019 | Volume: 114 | Issue: 8 | Pages: 1322-1342

10.14309/ajg.0000000000000264 | PMID 31205135 Get It

INTRODUCTION: Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology. METHODS: A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets. RESULTS: Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary. DISCUSSION: Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.
Gastrointestinal Manifestations of Rheumatological Diseases
Tolaymat, Omar , Abril, Andy , Lacy, Brian E. , Tolaymat, Omar A, Bowman, Andrew W. , Kröner, Paul T.

Mayo Clinic

American Journal of Gastroenterology | June 14, 2019 | Volume: 114 | Issue: 9 | Pages: 1441-1454

10.14309/ajg.0000000000000260 | PMID 31205138 Get It

Rheumatological diseases (RDs) represent a diverse group of diseases that are inherited or related to environmental factors. RDs frequently affect the gastrointestinal (GI) tract, and gastroenterologists are often asked to evaluate patients with symptoms thought to represent an underlying or coexisting RD. GI manifestations of RDs vary based on the organ involved as well as the extent and duration of involvement. Although most manifestations of RD are nonspecific and not life-threatening, the chronicity and severity of symptoms can be debilitating and may lead to serious injury. This narrative review discusses the most common RD encountered by gastroenterologists: systemic lupus erythematosus, systemic sclerosis (scleroderma), dermatomyositis/polymyositis, rheumatoid arthritis, Sjögren syndrome, overlap syndromes, mixed connective tissue disease, Ehlers-Danlos syndromes, and other vasculitides. Each section begins with a brief overview of the condition, followed by a discussion of the etiopathophysiology, physical examination findings, GI manifestations, diagnostic tools (i.e., serologic, imaging, endoscopic, and functional), and treatment options.
Mechanical Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Stent Retrievers vs Direct Aspiration vs a Combined Approach
Texakalidis, Pavlos , Giannopoulos, Stefanos , Karasavvidis, Theofilos , Rangel-Castilla, Leonardo , Rivet, Dennis J. , Reavey‐Cantwell, John , Rangel-Castilla, Leonardo

Mayo Clinic

Neurosurgery | June 14, 2019 | Volume: 86 | Issue: 4 | Pages: 464-477

10.1093/neuros/nyz258 | PMID 31313819 Get It

Abstract BACKGROUND Recent randomized control trials (RCTs) established that mechanical thrombectomy is superior to medical therapy for patients with stroke due to a large vessel occlusion. OBJECTIVE To compare the safety and efficacy profile of the different mechanical thrombectomy strategies. METHODS A random-effects meta-analysis was performed and the I 2 statistic was used to assess heterogeneity according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. RESULTS Nineteen studies with a total of 2449 patients were included. No differences were identified between the stent retrieval and direct aspiration groups in terms of modified Thrombolysis in Cerebral Infarction (mTICI) 2b/3 and mTICI 3 recanalization rates, and favorable outcomes (modified Rankin Scale [mRS] ≤ 2). Adverse event rates, including 90-d mortality, symptomatic intracerebral hemorrhage (sICH), and subarachnoid hemorrhage (SAH), were similar between the stent retrieval and direct aspiration groups. The use of the stent retrieval was associated with a higher risk of vasospasm (odds ratio [OR]: 2.98; 95% confidence interval [CI]: 1.10-8.09; I 2 : 0%) compared to direct aspiration. When compared with the direct aspiration group, the subgroup of patients who underwent thrombectomy with the combined approach as a first-line strategy had a higher likelihood of successful mTICI 2b/3 (OR: 1.47; 95% CI: 1.02-2.12; I 2 : 0%) and mTICI 3 recanalization (OR: 3.65; 95% CI: 1.56-8.54), although with a higher risk of SAH (OR: 4.33; 95% CI: 1.15-16.32). CONCLUSION Stent retrieval thrombectomy and direct aspiration did not show significant differences. Current available evidence is not sufficient to draw conclusions on the best surgical approach. The combined use of a stent retriever and aspiration as a first-line strategy was associated with higher mTICI 2b/3 and mTICI 3 recanalization rates, although with a higher risk of 24-h SAH, when compared with direct aspiration.
The cell biology of the hepatocyte: A membrane trafficking machine
Schulze, Ryan J. , Casey, Carol A. , McNiven, Mark A. , Schott, Micah B. , Casey, Carol A , McNiven, Mark A , Tuma, Pamela L.

Mayo Clinic

Journal of Cell Biology | June 14, 2019 | Volume: 218 | Issue: 7 | Pages: 2096-2112

10.1083/jcb.201903090 | PMID 31201265 Get It

The liver performs numerous vital functions, including the detoxification of blood before access to the brain while simultaneously secreting and internalizing scores of proteins and lipids to maintain appropriate blood chemistry. Furthermore, the liver also synthesizes and secretes bile to enable the digestion of food. These diverse attributes are all performed by hepatocytes, the parenchymal cells of the liver. As predicted, these cells possess a remarkably well-developed and complex membrane trafficking machinery that is dedicated to moving specific cargos to their correct cellular locations. Importantly, while most epithelial cells secrete nascent proteins directionally toward a single lumen, the hepatocyte secretes both proteins and bile concomitantly at its basolateral and apical domains, respectively. In this Beyond the Cell review, we will detail these central features of the hepatocyte and highlight how membrane transport processes play a key role in healthy liver function and how they are affected by disease.
PD-1 hi CD8 + resident memory T cells balance immunity and fibrotic sequelae
Wang, Zheng , Wang, Shaohua , Goplen, Nick P., Li, Chaofan , Cheon, In Su , Dai, Qigang , Huang, Su, Shan, Jinjun , Ma, Chaoyu , Ye, Zhenqing , Xiang, Min , Porquera, Eva-Carmona, Kohlmeier, Jacob E. , Kaplan, Mark H. , Johnson, Aaron J. , Vassallo, Robert , Kohlmeier, Jacob E , Kaplan, Mark H , Zhang, Nu , Johnson, Aaron J. , Vassallo, Robert , Sun, Jie , Li, Chaofan , Dai, Qigang , Limper, Andrew H. , Porquera, E.M. Carmona, Sun, Jie

Mayo Clinic

Science Immunology | June 14, 2019 | Volume: 4 | Issue: 36 | Pages: No page available

10.1126/sciimmunol.aaw1217 | PMID 31201259 Get It

Exhausted-like CD8 + resident memory T cells in the lung limit immune activation–driven fibrosis.